Navigation Links
Media invited to ACS Webinar on chemistry and entreprenuership and small/medium business
Date:4/15/2009

WASHINGTON, April 15, 2009 News media covering the chemical sciences, small businesses, and entrepreneurships are invited to join an American Chemical Society (ACS) Small & Medium Business Webinar Series on technology commercialization in lean times.

Scheduled for Thursday, April 23 from 2 3 p.m. Eastern Time, the teleconference will feature Craig Galbraith, MBA, Ph.D., Professor of Entrepreneurship and Technology Management and the GlaxoSmithKline Faculty Fellow in Economic Development at the Cameron School of Business at University of North Carolina in Wilmington. Galbraith is also an active private equity "angel" investor, works with numerous Department of Defense technology transfer agencies specializing in bio/chem warfare agent detection and port security technologies, and is currently the Vice-President of Commercialization for Horizon Vision Research, Inc., a start-up medical instruments R&D firm.

The topic for the teleconference is "Steps to successful technology commercialization for scientist entrepreneurs and small/medium businesses in lean times." Galbraith will discuss how to bring chemical/biopharma technology to commercialization in today's economy for entrepreneurs and small businesses

The ACS Small & Medium Business Webinar Series addresses current topics of interest to entrepreneurs and small & medium businesses in the chemical/biopharma enterprise. There will be a 30-minute presentation with Galbraith followed by a 25-minute Q & A session.

News media can tune into the conference without charge, but must register in advance at the ACS Industry Member Program Web site, which also provides information about future speakers. For additional information about upcoming speakers, click on the Small & Medium Business tab located at the top of the ACS Industry Member Programs page.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Related medicine news :

1. VIDEO from Medialink and Siemens: New Technology Makes Tracking Tumors Easier
2. NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue
3. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
4. Apollo Unifies All Patient Media With Enterprise Patient Media Manager
5. National Press Club to Host NEWSMAKER Media Briefing on Taiwans Experience in National Health Care Insurance
6. Grants Office CEO Available for Media Interviews on Stimulus Funding
7. VIDEO From Medialink and Siemens: Information Technology Helps Improve Healthcare
8. New Routes' Immigrant Project 'Egal Shidad' Aims to Solve Somali Mental Health Problems through New Media
9. VIDEO from Medialink and Bausch & Lomb: Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide See a New You
10. Dr. Rudy Kachmann, Neurosurgeon, Author, Lecturer & Founder of Kachmann Mind Body Institute Selects TransMedia Group as Agency of Record
11. Urgent Care Provider NextCare Opens Two Additional Immediate Care Clinics in Virginia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is the first technology to directly address the resolution to globally reduce the ... is a patented compound of FDA and TTB approved ingredients that when infused ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... dedicated to advancing the science and clinical practice of radiosurgery, announced today ... Registry, a multi-institutional, observational registry established to standardize data collection from patients ...
(Date:3/28/2017)... DC (PRWEB) , ... March 28, 2017 , ... WHO: ... Dr. Toni Bark , WHAT: , Medical doctors and PhD scientists will speak to ... written to President Trump in support of an independent vaccine safety commission. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Rosen Law Firm, a ... a class action lawsuit on behalf of purchasers of ... ) pursuant and/or traceable to Kitov,s initial public offering ... on the open market from November 20, 2015 through ... The lawsuit seeks to recover damages for Kitov investors ...
(Date:3/28/2017)... , March 29, 2017 ... Siteless CRO platform, announced today study results ... Managed Care Pharmacy, #AMCP2017, Managed Care and Specialty Pharmacy ... . Data in both posters demonstrated that pharmacist-led ... and protocol adherence. These factors are crucial to generating ...
(Date:3/28/2017)... , March 28, 2017 Emosis SAS, ... new business entity, Emosis Ltd, headquartered in Tel Aviv ... novel assays complementing the mother company existing technology platform and test ... sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. Emosis ...
Breaking Medicine Technology: